Unified Patent Court (UPC) analytics are now available. Check here

EP3713919

AGIOS PHARMACEUTICALS
Application Number
EP18821779A
Filing Date
Nov 21, 2018
Status
Granted And Under Opposition
Jun 30, 2023
Grant Date
Aug 2, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3713919B1 was granted on Aug 2, 2023 by Agios Pharmaceuticals The patent is currently Granted And Under Opposition.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BOTTI & FERRARIMay 2, 2024ADMISSIBLE
SANDOZMay 2, 2024ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP3307271B1
N/A
OppositionWO2012151451
N/A
OppositionUS8785450
N/A
OppositionWO2016201227
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.